MedPage Today Biogen Halts Work on Failed ALS Drug MedPage Today A phase III trial showed no benefit from the investigational drug dexpramipexole for amyotrophic lateral sclerosis (ALS), prompting its developer to cancel the program.
Read More:
Biogen Halts Work on Failed ALS Drug - MedPage
No comments:
Post a Comment